Physician profile
Michael Vrla
NPI 1598119679
$17,103.39
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,331 · 2022: $9,195 · 2023: $2,631 · 2024: $1,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,001 · Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,000.74 |
| Food and Beverage | $1,577.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $5,843.19 | 2022-2024 | |
| Arthrex, INC. | $5,358.77 | 2022-2024 | Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Medical Device Business Services, INC. | $2,984.00 | 2021 | |
| Kairos Surgical INC | $2,432.00 | 2022 | |
| Stryker Corporation | $326.83 | 2021 | |
| Depuy Synthes Sales INC. | $138.70 | 2023-2024 | Healix Knotless Peek, Truespan Orthocord, Milagro |
| Vericel Corporation | $19.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vrla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.